TCL Archive Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis December 27, 2013
TCL Archive VEGF Inhibitor Slows Thyroid Cancer Progression In Some Patients, Study Finds July 25, 2008